Ravindre Panchia to Pre-Exposure Prophylaxis
This is a "connection" page, showing publications Ravindre Panchia has written about Pre-Exposure Prophylaxis.
Connection Strength
1,072
-
Preferences for HIV pre-exposure prophylaxis formulations and delivery among young African women: results of a discrete choice experiment. J Int AIDS Soc. 2025 Feb; 28(2):e26422.
Score: 0,191
-
High recent PrEP adherence with point-of-care urine tenofovir testing and adherence counselling among young African women: results from the INSIGHT cohort. J Int AIDS Soc. 2024 Dec; 27(12):e26389.
Score: 0,189
-
Interest in Oral Pre-exposure Prophylaxis Among Men Who Have Sex with Men and Transfeminine Persons in HPTN 075, a Multi-center HIV Prevention Study in Sub-Saharan Africa (2015-2017). AIDS Behav. 2025 Feb; 29(2):411-419.
Score: 0,187
-
Interest in I-PrEP and Willingness to Participate in Clinical Trials Among Men and Transfeminine Persons Who have Sex with Men in Sub-Saharan Africa: Quantitative and Qualitative Findings from HPTN 075. AIDS Behav. 2024 Jul; 28(7):2361-2377.
Score: 0,182
-
HIV Incidence Among Pregnant and Nonpregnant Women in the FACTS-001 Trial: Implications for HIV Prevention, Especially PrEP Use. J Acquir Immune Defic Syndr. 2021 12 01; 88(4):376-383.
Score: 0,154
-
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077. AIDS Behav. 2020 Sep; 24(9):2520-2531.
Score: 0,141
-
The fourth generation AlereTM HIV Combo rapid test improves detection of acute infection in MTN-003 (VOICE) samples. J Clin Virol. 2017 09; 94:15-21.
Score: 0,028